Khairi Hajaji

Hamad Medical Corporation

Papers

1

Total Citations

40

H-Index

1

About

Dr. Khairi Hajaji is a distinguished surgical oncologist whose research has significantly advanced the understanding and management of gastrointestinal stromal tumors (GISTs), particularly within the Middle Eastern population. His landmark study, "Clinical presentation, management and outcomes of gastrointestinal stromal tumors" (2014, 40 citations), provides critical insights into the incidence, clinical presentation, and treatment outcomes of GISTs in Qatar. By conducting a comprehensive retrospective review spanning nearly two decades (1995–2012), Dr. Hajaji established foundational epidemiological data for this rare sarcoma in a region where such information was previously scarce. His work highlights the unique clinical patterns and management challenges faced in this demographic, offering evidence-based guidance for surgical and medical interventions. Beyond this seminal paper, Dr. Hajaji’s contributions have helped shape regional oncology protocols, emphasizing the importance of tailored treatment strategies. His research is widely cited by clinicians and scholars seeking to improve GIST outcomes in diverse populations, cementing his role as a key voice in gastrointestinal oncology and a bridge between global best practices and local healthcare realities.

Research Focus

Key Achievements

1
H-Index
1
Papers
40
Total Citations
40
Avg Citations/Paper
🏆 Most Cited Paper
Clinical presentation, management and outcomes of gastrointestinal stromal tumors
40 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Hamad Medical Corporation

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago